Literature DB >> 26618431

Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.

Brigid S Boland1, Parambir S Dulai1, Michael Chang1, William J Sandborn1, Barrett G Levesque1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26618431      PMCID： PMC5824985          DOI： 10.1038/ajg.2015.326

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  7 in total

1.  IMP-16 in Pseudomonas putida and Pseudomonas stutzeri: potential reservoirs of multidrug resistance.

Authors:  Ana P D'A Carvalho-Assef; Marisa Z R Gomes; André R A Silva; Lúcia Werneck; Caio A S Rodrigues; Maria J Souza; Marise D Asensi
Journal:  J Med Microbiol       Date:  2010-05-27       Impact factor: 2.472

Review 2.  Community-acquired Pseudomonas stutzeri vertebral osteomyelitis in a previously healthy patient: case report and review.

Authors:  R B Reisler; H Blumberg
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

Review 3.  Listeria--review of epidemiology and pathogenesis.

Authors:  Vidhya Ramaswamy; Vincent Mary Cresence; Jayan S Rejitha; Mohandas Usha Lekshmi; K S Dharsana; Suryaprasad Priya Prasad; Helan Mary Vijila
Journal:  J Microbiol Immunol Infect       Date:  2007-02       Impact factor: 4.399

Review 4.  Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.

Authors:  Parambir S Dulai; Kimberly D Thompson; Heather B Blunt; Marla C Dubinsky; Corey A Siegel
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-22       Impact factor: 11.382

5.  Vedolizumab as induction and maintenance therapy for Crohn's disease.

Authors:  William J Sandborn; Brian G Feagan; Paul Rutgeerts; Stephen Hanauer; Jean-Frédéric Colombel; Bruce E Sands; Milan Lukas; Richard N Fedorak; Scott Lee; Brian Bressler; Irving Fox; Maria Rosario; Serap Sankoh; Jing Xu; Kristin Stephens; Catherine Milch; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

6.  A suspected hospital outbreak of pseudobacteremia due to Pseudomonas stutzeri.

Authors:  T F Keys; L J Melton; M D Maker; D M Ilstrup
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

7.  [Community-acquired Pseudomonas stutzeri meningitis in an immunocompetent patient].

Authors:  Mustafa Sünbül; Muammer Zivalioğlu; Nuriye Taşdelen Fişgin
Journal:  Mikrobiyol Bul       Date:  2009-01       Impact factor: 0.622
  7 in total
  7 in total

1.  Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Authors:  Joseph Meserve; Satimai Aniwan; Jenna L Koliani-Pace; Preeti Shashi; Aaron Weiss; David Faleck; Adam Winters; Shreva Chablaney; Gursimran Kochhar; Brigid S Boland; Siddharth Singh; Robert Hirten; Eugenia Shmidt; Justin G Hartke; Prianka Chilukuri; Matthew Bohm; Sashidhar Varma Sagi; Monika Fischer; Dana Lukin; David Hudesman; Shannon Chang; Youran Gao; Keith Sultan; Arun Swaminath; Nitin Gupta; Sunanda Kane; Edward V Loftus; Bo Shen; Bruce E Sands; Jean-Frederic Colombel; Corey A Siegel; William J Sandborn; Parambir S Dulai
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-27       Impact factor: 11.382

Review 2.  Unintended Immunological Consequences of Biologic Therapy.

Authors:  Sarah E Henrickson; Melanie A Ruffner; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

3.  Infective endocarditis caused by Pseudomonas stutzeri in a patient with Marfan syndrome: Case report and brief literature review.

Authors:  Ahmad Shalabi; Tristan Ehrlich; Hans-Joachim Schäfers; Sören L Becker
Journal:  IDCases       Date:  2017-08-02

4.  Emergence and Genetic Characterization of Plasmid-Encoded VIM-2-Producing Pseudomonas stutzeri with Novel Integron In1998 Isolated from Cerebrospinal Fluid.

Authors:  Shuxiu Liu; Hao Xu; Xiaobing Guo; Shuang Li; Qian Wang; Yuan Li; Ruishan Liu; Jianjun Gou
Journal:  Infect Drug Resist       Date:  2021-08-24       Impact factor: 4.003

5.  The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.

Authors:  Parambir S Dulai; Siddharth Singh; Xiaoqian Jiang; Farhad Peerani; Neeraj Narula; Khadija Chaudrey; Diana Whitehead; David Hudesman; Dana Lukin; Arun Swaminath; Eugenia Shmidt; Shuang Wang; Brigid S Boland; John T Chang; Sunanda Kane; Corey A Siegel; Edward V Loftus; William J Sandborn; Bruce E Sands; Jean-Frederic Colombel
Journal:  Am J Gastroenterol       Date:  2016-06-14       Impact factor: 12.045

6.  Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.

Authors:  Bharati Kochar; Yue Jiang; Millie D Long
Journal:  J Clin Gastroenterol       Date:  2021-04-01       Impact factor: 3.174

7.  Prosthetic vascular graft infection and prosthetic joint infection caused by Pseudomonas stutzeri.

Authors:  Michael J Bonares; Alon Vaisman; Abdu Sharkawy
Journal:  IDCases       Date:  2016-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.